Featured
How to review scientific literature
In this episode, Daniel G. Haller, MD, of the University of Pennsylvania joins David H. Henry, MD, to talk about the best ways to read and review scientific literature.
Latest News
February 21, 2019
Lawsuit against ABIM draws $200,000 in donation support
February 21, 2019
Hematology News
Hem-Onc Board Review
Clinical Reviews
February 14, 2019
Chronic Myeloid Leukemia: A Review of TKI Therapy
February 14, 2019
Hospital Physician: Hematology/Oncology
February 6, 2019
Chronic Myeloid Leukemia: Evaluation and Diagnosis
February 6, 2019
Hospital Physician: Hematology/Oncology
January 23, 2019
Aplastic Anemia: Current Treatment
January 23, 2019
Hospital Physician: Hematology/Oncology
January 18, 2019
Aplastic Anemia: Evaluation and Diagnosis
January 18, 2019
Hospital Physician: Hematology/Oncology
October 1, 2018
Management of Metastatic Gastric Cancer
October 1, 2018
Hospital Physician: Hematology/Oncology
Conference Coverage
February 21, 2019
First-line avelumab/axitinib for RCC benefits wide range of patients
February 21, 2019
Oncology Practice
February 20, 2019
ARAMIS: Darolutamide shines in nonmetastatic CRPC
February 20, 2019
Oncology Practice
February 20, 2019
Supplementary compression doesn’t improve DVT odds in critically ill
February 20, 2019
Hematology News
Conference Coverage Videos
February 8, 2019
Increased risk of second cancers in mycosis fungoides
February 8, 2019
Hematology Times
February 6, 2019
Cerdulatinib yields ‘encouraging’ results in CTCL, PTCL
February 6, 2019
Hematology Times
February 5, 2019
Combo emerges as bridge to transplant in rel/ref PTCL
February 5, 2019
Hematology Times
January 19, 2019
Four-drug combo shows durable responses in relapsed/refractory lymphomas
January 19, 2019
Hematology Times
Business of Medicine
February 21, 2019
Lawsuit against ABIM draws $200,000 in donation support
February 21, 2019
Hematology News
February 20, 2019
Health spending: Boomers will spike costs, but growing uninsured will soften their impact
February 20, 2019
Oncology Practice
FDA/CDC
February 20, 2019
FDA grants priority review to polatuzumab vedotin for DLBCL
February 20, 2019
Hematology News
February 20, 2019
FDA approves turoctocog alfa pegol for hemophilia A
February 20, 2019
Hematology News
February 13, 2019
FDA approves daratumumab split-dosing regimen in MM
February 13, 2019
Hematology News
February 7, 2019
FDA: 246 new reports on breast implant-associated lymphoma
February 7, 2019
Hematology News
Perspectives
February 20, 2019
Diagnostic metal rod, eyeball extramission, fungal foot fetish
February 20, 2019
Hematology News
February 13, 2019
Love hormone plein air, posh preused Kleenex, and dieting plague vectors
February 13, 2019
Hematology News
Hematology
February 20, 2019
ICYMI: Rivaroxaban reduces VTE incidence in ambulatory cancer patients
February 20, 2019
Oncology Practice
February 20, 2019
Supplementary compression doesn’t improve DVT odds in critically ill
February 20, 2019
Hematology News
February 16, 2019
ICYMI: Andexanet alfa reduces anti–factor Xa activity from apixaban, rivaroxaban
February 16, 2019
Hematology News
February 13, 2019
Inhibitor risk nears zero after 75 days in previously untreated hemophilia A
February 13, 2019
Hematology News
Follicular Lymphoma
February 11, 2019
Anthracyclines, bendamustine are options for grade 3A follicular lymphoma
February 11, 2019
Hematology News
February 11, 2019
Daratumumab disappoints in non-Hodgkin lymphoma trial
February 11, 2019
Hematology News
February 10, 2019
BCL expression intensity key in distinguishing FL lesions
February 10, 2019
Hematology News
Breast Cancer
February 12, 2019
Breast cancer recurrence lower, survival better with dose-intensified regimens
February 12, 2019
Oncology Practice
February 7, 2019
Therapy ups breast cancer survivors’ cardiac risks
February 7, 2019
Oncology Practice